Clinical Trial Update: Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the safety and efficacy of extracorporeal photoimmune therapy with UVADEX for rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• UVADEX (methoxsalen)

Snippet

Sponsor: Mallinckrodt | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED